Regression of all untreated lesions in multifocal low-grade meningioma following fractionated stereotactic radiotherapy-abscopal effect or spontaneous regression? : Case report and review of the literature
- PMID: 38871938
- DOI: 10.1007/s00066-024-02248-0
Regression of all untreated lesions in multifocal low-grade meningioma following fractionated stereotactic radiotherapy-abscopal effect or spontaneous regression? : Case report and review of the literature
Abstract
Purpose: Abscopal effects have been reported predominantly in metastatic cancers, indicating a radiographic response in a lesion that has not been included in the radiotherapy target volume. The response is interpreted as a humoral immune response to radiotherapy-generated tumour-specific antigens. In this case study, we present the first histologically confirmed multifocal low-grade meningioma with spontaneous regression of all other lesions after conventionally fractionated stereotactic radiotherapy (RT).
Case report: Two localisations, right frontal and right spheno-orbital, were resected at the time of the initial diagnosis in a 66-year-old woman. RT was performed 1 year later to a progressive occipital lesion at the cerebral falx.
Results: Regular magnetic resonance imaging (MRI) showed slightly decreasing tumour volume in untreated lesions 1 year after RT and continued during further follow-up. Up to > 7 years after treatment, MRI demonstrated an almost complete response of all initial lesions. Two prior reports with meningioma were published in one patient with an atypical meningioma after conventionally fractionated RT and another patient with an intracranial meningiomatosis after radiosurgery.
Conclusion: This case study supports the concepts of treating only progressive or symptomatic meningioma lesions locally and careful regular MRI surveillance for further assessment. Potential active interventions to trigger an abscopal effect are currently not known. Further research of this beneficial effect for our patients should be supported.
Keywords: Grade I Meningioma; Immune microenvironment; Immune response; Meningiomatosis; Neoplasms, nerve tissue.
© 2024. Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Conflict of interest: M. Pinkawa, J. Boström, S. Temming, A. Schäfer, A. Kovács and A. Boström declare that they have no competing interests.
Similar articles
-
Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.J Neurooncol. 2017 Sep;134(2):407-416. doi: 10.1007/s11060-017-2540-7. Epub 2017 Jun 30. J Neurooncol. 2017. PMID: 28667597
-
Major complications from radiotherapy following treatment for atypical meningiomas.Neurosurg Focus. 2019 Jun 1;46(6):E5. doi: 10.3171/2019.3.FOCUS1930. Neurosurg Focus. 2019. PMID: 31153147
-
Long-term outcomes of fractionated stereotactic radiotherapy for intracranial skull base benign meningiomas in single institution.Jpn J Clin Oncol. 2011 Apr;41(4):462-8. doi: 10.1093/jjco/hyq231. Epub 2010 Dec 22. Jpn J Clin Oncol. 2011. PMID: 21177777
-
Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas : long-term experience and review of the literature.Strahlenther Onkol. 2006 Nov;182(11):635-40. doi: 10.1007/s00066-006-1548-2. Strahlenther Onkol. 2006. PMID: 17072520 Review.
-
[Stereotactic radiotherapy for intracranial meningioma].Cancer Radiother. 2012 Jun;16 Suppl:S79-89. doi: 10.1016/j.canrad.2011.07.249. Epub 2012 May 29. Cancer Radiother. 2012. PMID: 22652300 Review. French.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources